MOH at a glance
Molina Healthcare (MOH, SEC CIK 1179929) filed its latest 10-K annual report on February 10, 2026, a 10-Q quarterly report on July 23, 2026, an 8-K current report on July 22, 2026 and Form 4 insider filings as recently as October 2, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Molina Healthcare (MOH) reported revenue of $45.4 billion (up 11.7% from FY2024) and net income of $472.0 million. Diluted EPS was $8.92.
- As of June 30, 2026, 39 institutional investment managers tracked by SignalX reported holding Molina Healthcare (MOH) shares worth $6.6 billion in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $45.4B
- +11.7% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 39 funds
- $6.6B · +0 vs prior quarter
- Latest 8-K
- Jul 22, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Risk Factors
- Medicaid rate risk from state contracts, with top 4 states generating $17.3B, 54% of Medicaid premium revenue in 2025
- Marketplace subsidy uncertainty due to expiration of advanced premium tax credits (APTCs) end of 2025, affecting enrollment and pricing
- Cybersecurity risks from third-party vendors and internal access, exposing sensitive member data and risking regulatory fines or service interruptions
- Competitive risk from contract renewals in 21 states; failure to renew could materially reduce premium revenue, 75% of consolidated premium in 2025
- Acquisition integration risk with potential delays, cost overruns, and cultural mismatches threatening realization of expected earnings and synergies
Management Discussion & Analysis
- Revenue $45.4B, up 12% YoY; premium revenue $43.1B, up 11% ($4.4B increase)
- Net income $472M, down from $1,179M; operating margin 1.7% (781M/$45.4B) vs 3.9%
- Best segment Medicaid: incremental $9B annual premium revenue new contracts; worst affected overall by 260bps MCR increase to 91.7% from 89.1%
- Interest expense $192M up from $118M; G&A ratio 6.6% down slightly from 6.7%; capex (depreciation) $195M vs $186M; no buyback or dividend data
- 2026 outlook includes $6B premium Florida Medicaid contract start expected Q4; growth focus on acquisitions and Medicaid expansions
Business Overview
- Core business: Managed healthcare services focusing on Medicaid, Medicare, and Marketplace insurance segments
- New emphasis: Significant membership growth in Marketplace (655,000 members, up 252,000 YoY) and ConnectiCare acquisition integration
- Strategic shift: Exit from MAPD in 13 states, shifting focus to higher acuity dual-eligible Medicare populations
- Quantitative highlight: Medical Cost Ratio (MCR) increased notably across segments; e.g., Marketplace MCR rose to 90.6% from 75.4% in 2024
- Noteworthy fact: $1 billion new stock repurchase authorization in 2025 with $500 million repurchased plus $350 million spent on ConnectiCare acquisition
AI summary of the MOH 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 results covered quarter ended June 30, 2026
- Full-year 2026 earnings guidance increased, signaling stronger expected profitability
Item 7.01: Regulation FD Disclosure
- Illinois HFS intends to award Molina’s Illinois subsidiary a HealthChoice Illinois Medicaid managed-care contract
- Potential expansion of Molina’s Illinois Medicaid membership and revenue base
Item 5.02: Departure/Appointment of Directors or Principal Officers
- May 6, 2026 Annual Meeting held, but provided text omits the specific officer or director action
- Investor impact cannot be assessed without the remainder of Item 5.02
Item 5.07: Submission of Matters to a Vote of Security Holders
- 90.55% shareholder participation; all ten director nominees elected through 2027 annual meeting
- Say-on-pay approved narrowly, with 22,459,321 votes for versus 20,116,888 against
AI summaries of MOH 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for MOH
Don't miss the next MOH filing
- Alerts as it files. A push when MOH files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut MOH, by share count.
- Ask anything. An AI agent that reads every MOH filing and answers with sources.
MOH alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| ROMNEY RONNA | A | Oct 1, 2026 | 304 | $180.85 |
| ZORETIC RICHARD C | A | Oct 1, 2026 | 304 | $180.85 |
| SOISTMAN FRANCIS S JR | A | Oct 1, 2026 | 304 | $180.85 |
| WOLF DALE B | A | Oct 1, 2026 | 304 | $180.85 |
| ORLANDO STEVEN J | A | Oct 1, 2026 | 304 | $180.85 |
| BRASIER BARBARA L | A | Oct 1, 2026 | 304 | $180.85 |
| Lockhart Stephen H | A | Oct 1, 2026 | 304 | $180.85 |
| Schapiro Richard M | A | Oct 1, 2026 | 304 | $180.85 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $40.6B | $45.4B |
| Operating Income | - | $1.7B | $781.0M |
| Net Income | $1.1B | $1.2B | $472.0M |
| Op. Margin | - | 4.2% | 1.7% |
| Net Margin | - | 2.9% | 1.0% |
| Balance Sheet | |||
| Total Assets | $14.9B | $15.6B | $15.6B |
| Equity | - | $4.5B | $4.1B |
| ROE | - | 26.2% | 11.6% |
| Per Share | |||
| EPS | $18.77 | $20.42 | $8.92 |
| Cash Flow | |||
| Operating CF | - | $644.0M | -$535.0M |
| CapEx | $84.0M | $100.0M | $101.0M |
Source: XBRL data in Molina Healthcare (MOH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate MOH share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 39 | $6.61B |
| Q1 2026 | 39 | $3.79B |
| Q4 2025 | 35 | $4.41B |
| Q3 2025 | 37 | $5.56B |
| Q2 2025 | 34 | $7.52B |
| Q1 2025 | 30 | $5.86B |
| Q4 2024 | 27 | $4.69B |
| Q3 2024 | 22 | $2.41B |
- AQR Capital Management+697.2K (+24%)
- Goldman Sachs Group+579.7K (+80%)
- Renaissance Technologies LLC+292.8K (+1316%)
- T. Rowe Price Group+267.0K (+27%)
- BlackRock+203.1K (+3%)
- FMR LLC (Fidelity)−1.33M (-42%)
- Citadel Advisors LLC−179.9K (-81%)
- Citigroup−129.5K (-38%)
- Two Sigma Investments−84.4K (-6%)
- JPMorgan Chase & Co−65.4K (-30%)
- StoneX Group Inc.+1.6K
- Mangrove Partners−5.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 263 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
MOH filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| 4 | Oct 2, 2026 | - | - | - |
| SC 13G | Sep 3, 2026 | - | - | |
| 10-Q | Jul 23, 2026 | Jun 30, 2026 | - | |
| 8-K | Jul 22, 2026 | - | Analysis | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 8-K | Jun 10, 2026 | - | Analysis | |
| 4 | May 15, 2026 | - | - | |
| SC 13G | May 14, 2026 | - | - | |
| 8-K | May 11, 2026 | - | Analysis |
Related Health Care companies
- ALHC · Alignment Healthcare, Inc.Hospital & Medical Service Plans
- CNC · Centene CorporationHospital & Medical Service Plans
- CI · CignaHospital & Medical Service Plans
- CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DEHospital & Medical Service Plans
- ELV · Elevance HealthHospital & Medical Service Plans
- HUM · HumanaHospital & Medical Service Plans
- OSCR · Oscar Health, Inc.Hospital & Medical Service Plans
- TRUP · TRUPANION, INC.Hospital & Medical Service Plans
MOH SEC filings: frequently asked questions
Which institutions hold MOH stock?
As of June 30, 2026, the largest Molina Healthcare (MOH) holders among the 13F filers tracked by SignalX were BlackRock ($1.5 billion), AQR Capital Management ($806.9 million), Vanguard Portfolio Management LLC ($638.1 million), Vanguard Capital Management LLC ($538.6 million), FMR LLC (Fidelity) ($428.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was MOH's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Molina Healthcare (MOH) reported revenue of $45.4 billion (up 11.7% from FY2024) and net income of $472.0 million. Diluted EPS was $8.92. The figures come from the XBRL data in the 10-K.
What are the main risks in MOH's latest 10-K?
In the 10-K filed February 10, 2026, Molina Healthcare (MOH) flagged: Medicaid rate risk from state contracts, with top 4 states generating $17.3B, 54% of Medicaid premium revenue in 2025. Marketplace subsidy uncertainty due to expiration of advanced premium tax credits (APTCs) end of 2025, affecting enrollment and pricing. (AI summary of the Risk Factors section.)
What did MOH report in its latest 8-K?
Molina Healthcare (MOH) filed an 8-K on July 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 2026 results covered quarter ended June 30, 2026.
What are the latest MOH SEC filings?
Molina Healthcare (MOH) filed its latest 10-K annual report on February 10, 2026, a 10-Q quarterly report on July 23, 2026, an 8-K current report on July 22, 2026 and a Form 4 insider filing on October 2, 2026.
What is MOH's SEC CIK number?
Molina Healthcare (MOH)'s SEC Central Index Key (CIK) is 1179929. EDGAR lists every MOH filing under that number.
Ask anything about MOH
The research agent reads MOH's filings, financials, insider trades and 13F holders, then answers with sources.